Drug importation is here. Kind of
Yesterday, the Trump administration put out a pair of long-expected policies that would allow for the importation of cheap Canadian drugs. But each faces enough roadblocks to tamp down industry concerns about a sweeping change to the status quo.
As STAT’s Nicholas Florko reports, the Health and Human Services plan would create two means of importing drugs. In one, states, wholesalers, and pharmacies could apply for HHS approval to import certain medicines from Canada. In a second, drug companies could voluntarily import their own products from countries where they’re cheaper, using a loophole that would cut out middlemen in the supply chain.
That second pathway might not be terribly popular with manufacturers. And the first one has managed to irk drug makers, pharmacists, and public health officials alike — to say nothing of actual Canadians. But it has proved popular with some governors, and HHS Secretary Alex Azar said the administration “will move as quickly as humanly possible” to enact the policy. He also said “fervently committed” twice.
Read more.
As STAT’s Nicholas Florko reports, the Health and Human Services plan would create two means of importing drugs. In one, states, wholesalers, and pharmacies could apply for HHS approval to import certain medicines from Canada. In a second, drug companies could voluntarily import their own products from countries where they’re cheaper, using a loophole that would cut out middlemen in the supply chain.
That second pathway might not be terribly popular with manufacturers. And the first one has managed to irk drug makers, pharmacists, and public health officials alike — to say nothing of actual Canadians. But it has proved popular with some governors, and HHS Secretary Alex Azar said the administration “will move as quickly as humanly possible” to enact the policy. He also said “fervently committed” twice.
Read more.
No hay comentarios:
Publicar un comentario